These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3161091)

  • 1. Isolation of suppressor-like T cells from bacteria-free allogeneic bone marrow chimeras.
    Truitt RL; Shih CC
    Prog Clin Biol Res; 1985; 181():451-4. PubMed ID: 3161091
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor cells detected in murine bone marrow chimeras.
    Imamura M
    Jpn J Exp Med; 1986 Oct; 56(5):221-8. PubMed ID: 2949096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemic effect of interleukin-2 on spontaneous development of leukemia after H-2-compatible allogenic bone marrow transplantation in AKR/J mice.
    Hashino S
    Hokkaido Igaku Zasshi; 1994 May; 69(3):601-13. PubMed ID: 7927184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S; Kamisaku H; Sado T
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
    Johnson BD; Hanke CA; Becker EE; Truitt RL
    Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
    Johnson BD; McCabe C; Hanke CA; Truitt RL
    J Immunol; 1995 May; 154(10):5542-54. PubMed ID: 7730653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of leukemia and the increase of plasma levels of lipid-bound sialic acid by allogeneic bone marrow transplantation in mice.
    Wustrow TP; Katopodis N; Stock CC; Good RA
    Cancer Res; 1985 Mar; 45(3):1097-100. PubMed ID: 3882223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
    Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Truitt RL; Rose WC; Rimm AA; Saltzstein EC
    Adv Exp Med Biol; 1976; 73 Pt B():331-9. PubMed ID: 793340
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study on the location of synthetic sites of the fourth and fifth components of the complement system in allogeneic bone marrow chimeras and hepatocyte transplantation chimeras].
    Geng L
    Hokkaido Igaku Zasshi; 1986 Mar; 61(2):289-97. PubMed ID: 3522387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD.
    Morohashi T; Ogasawara K; Kitaichi N; Iwabuchi K; Onoé K
    Bone Marrow Transplant; 2000 Nov; 26(10):1069-76. PubMed ID: 11108305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM; Rimm AA; Rose WC; Saltzstein EC
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.